Three-arm randomised controlled phase 2 study comparing pemetrexed and erlotinib to either pemetrexed or erlotinib alone as second-line treatment for never-smokers with non-squamous non-small cell lung cancer

Ki Hyeong Lee, Jung Shin Lee, Sang‐We Kim et al. · European Journal of Cancer · 2013

Cited by 77 works. doi:10.1016/j.ejca.2013.06.035

Authors

References